Context:Chronic periodontitis (CP) and diabetes mellitus are associated with increased oxidative damage to DNA with formation of 8-hydroxydeoxyguanosine (8-OHdG). The aim of this study was to evaluate the change in gingival crevicular fluid (GCF) levels of 8-OHdG and glycosylated hemoglobin (HbA1c) by 3 months after scaling and root planing (SRP), in CP patients with and without Type II diabetes mellitus.Settings and Design:Sixteen patients with CP, 16 patients with CP and Type II diabetes mellitus (CP-D), and 16 systemically healthy individuals with clinically healthy periodontium who served as controls were included in the study.Materials and Methods:The clinical parameters (plaque index [PI], probing depth [PD], clinical attachment level [CAL], and bleeding on probing [BOP%]), HbA1c levels, and GCF 8-OHdG levels were measured at baseline. All the patients except controls were treated with SRP followed by evaluation of the above-mentioned clinical and biochemical parameters after 3 months.Statistical Analysis Used:Statistical analysis was performed using paired t-test, independent t-test, and Mann–Whitney U-test.Results:After SRP, CP-D group showed a greater reduction in PI, PD, BOP%, and greater gain in CAL when compared to CP patients (P < 0.05). Levels of 8-OHdG and HbA1c in CP-D patients also showed a greater reduction, 3 months after SRP when compared to CP patients (P < 0.05).Conclusions:GCF 8-OHdG levels, HbA1c levels, and clinical parameters were reduced significantly in CP and CP-D patients, with maximum reduction achieved in CP-D patients 3 months after SRP.
Background:In both states of health and disease, the integrity of connective tissue along with regulation in formation of bones are well maintained by periostin (POSTN) which is a matricellular protein secreted by fibroblasts. The present study aimed to assess the gingival crevicular fluid (GCF) POSTN levels in patients with chronic periodontitis (CP) and aggressive periodontitis and to compare them with that of healthy controls.Materials and Methods:A total of 39 individuals were recruited and allocated into the healthy group, and two periodontitis groups (the chronic and the aggressive types) (13 in each group). The samples of GCF fluid were collected using microcapillary pipette. The POSTN levels were estimated using the enzyme-linked immunosorbent assay.Results:The mean levels of total POSTN in GCF fluid (in pg/μl) were 182.41, 79.87, and 49.28 for the healthy, CP, aggressive periodontitis groups, respectively. There was a statistically significant difference between the groups with P < 0.05. Furthermore, there were statistically significant differences when compared among the groups with P < 0.05. When all three groups were examined together, there were negative correlations between GCF POSTN levels and clinical parameters.Conclusion:The GCF POSTN levels reduced with an increase in the severity of the periodontitis. With the present study results, we could conclude that the GCF POSTN level can be considered as a dependable marker in periodontal disease diagnosis, disease activity, and healing.
Tuberculosis (TB) is an inflammatory granulomatous disease that rarely presents as primary lesion in gingiva. Gingival involvement has been reported in only a very limited number of cases. A 13-year-old boy presented with gingival enlargement in the maxillary and mandibular anterior region associated with enlargement of lower lip with no systemic manifestations. He had a history of tuberculous lymphadenitis before 5 years which was inadequately treated. The patient's erythrocyte sedimentation rate was 70 mm/h. Histopathological report of the gingival lesion revealed noncaseating granulomas with nests of epithelioid cells and multinucleated Langhans giant cells. The patient was then referred to a physician for management, who initiated active antitubercular treatment following which the condition resolved. The aim of this article is to emphasize the importance of early diagnosis of primary TB of the gingiva which may be misdiagnosed when oral lesions are not associated with any apparent systemic infection.
BACKGROUND Chronic periodontitis is defined as "an infectious disease resulting in inflammation within the supporting tissues of the teeth and progressive attachment loss and bone loss." Chronic periodontitis is associated with a widely diverse and complex subgingival microbiota encompassing both Gram-positive and Gram-negative bacteria, facultative and anaerobic organisms, viruses and yeasts. More than 500 bacterial strains have been recovered from the subgingival plaque. Plaque also comprises of fungal species like Candida albicans, Candida glabrata, Candida tropicalis, Candida krusei, and Candida dubliniensis. Most of these strains are commensals and some are potential opportunistic pathogens.The objective of the study is to examine the prevalence of Candida albicans (dimorphic fungus) in subgingival plaque samples of patients with chronic periodontitis. MATERIALS AND METHODSIt's a cross-sectional study of 108 chronic periodontitis patients, their age ranged from 30 to 55 years. Clinical parameters like plaque index (PlI), probing depth (PD), and clinical attachment level (CAL) were measured. We also observed the smokers from the analysed patients. Suitable microbiological media was used to culture C. albicans from clinical plaque samples. Data analysed with suitable statistical methods. RESULTSClinical parameters of PlI, PD, and CAL, disease severity and sex revealed no significant relation between C. albicans and periodontitis patients, while smoking of individuals significantly correlated with the presence of the C. albicans. CONCLUSIONAlthough C. albicans infection occurred in chronic periodontitis patients, smokers were at higher risk for C. albicans infection than non-smokers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.